| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The effect of clinical pharmacy services on patients with essential hypertension.
|
Circulation
|
1973
|
3.77
|
|
2
|
Pharmaceutical care services and results in project ImPACT: hyperlipidemia.
|
J Am Pharm Assoc (Wash)
|
2000
|
1.63
|
|
3
|
Drug-related hospital admissions.
|
Am J Hosp Pharm
|
1976
|
1.30
|
|
4
|
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
|
Am Heart J
|
1999
|
1.09
|
|
5
|
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
|
Arch Intern Med
|
2000
|
1.01
|
|
6
|
Total error assessment of five methods for cholesterol screening.
|
Clin Chem
|
1993
|
0.99
|
|
7
|
Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study.
|
Clin Cardiol
|
1991
|
0.94
|
|
8
|
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus.
|
Food Chem Toxicol
|
2008
|
0.93
|
|
9
|
The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide.
|
Clin Pharmacol Ther
|
1989
|
0.89
|
|
10
|
Lipid management: tools for getting to the goal.
|
Am J Manag Care
|
2001
|
0.85
|
|
11
|
Pharmacy management of hypertensive patients.
|
J Am Pharm Assoc
|
1974
|
0.83
|
|
12
|
Treatment of hypercholesterolemia in black patients.
|
J Natl Med Assoc
|
1988
|
0.83
|
|
13
|
The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
|
Clin Ther
|
1997
|
0.82
|
|
14
|
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study.
|
Clin Pharmacol Ther
|
1991
|
0.81
|
|
15
|
Use of antihypertensive agents in patients with glucose intolerance.
|
Clin Pharm
|
1986
|
0.80
|
|
16
|
Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients.
|
Clin Pharm
|
1993
|
0.80
|
|
17
|
Effect of telephone follow-up on medication compliance.
|
Am J Hosp Pharm
|
1981
|
0.79
|
|
18
|
The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins.
|
Pharmacotherapy
|
1986
|
0.79
|
|
19
|
Methods of modifying compliance behavior in hypertensive patients.
|
Drug Intell Clin Pharm
|
1981
|
0.78
|
|
20
|
Renin profile, race, and antihypertensive efficacy with atenolol and labetalol.
|
J Hum Hypertens
|
1991
|
0.78
|
|
21
|
The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy.
|
Hosp Pharm
|
1985
|
0.78
|
|
22
|
The effect of phenylpropanolamine on ambulatory blood pressure.
|
Clin Pharmacol Ther
|
1986
|
0.78
|
|
23
|
Analytic and clinical performance of two compact cholesterol-testing devices.
|
Pharmacotherapy
|
1998
|
0.77
|
|
24
|
Effect of high-dose ibuprofen on 24-hour blood pressure in healthy women.
|
Drug Intell Clin Pharm
|
1987
|
0.77
|
|
25
|
Interim report from project ImPACT: hyperlipidemia.
|
J Am Pharm Assoc (Wash)
|
1998
|
0.77
|
|
26
|
Initial experiences with a pharmacy clinic in a hospital-based group medical practice.
|
Am J Hosp Pharm
|
1981
|
0.76
|
|
27
|
Clinical evaluation of a finger oscillometric blood pressure device.
|
DICP
|
1991
|
0.76
|
|
28
|
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.
|
Food Chem Toxicol
|
2008
|
0.76
|
|
29
|
Antihypertensive effect of hydrochlorothiazide administered once or twice daily.
|
Clin Pharm
|
1983
|
0.76
|
|
30
|
The effect of ranitidine and cimetidine on single-dose diltiazem pharmacokinetics.
|
Pharmacotherapy
|
1985
|
0.75
|
|
31
|
Commentary on Langley and McKenney Papers.
|
Value Health
|
1998
|
0.75
|
|
32
|
Antihypertensive drug therapy.
|
J Am Pharm Assoc
|
1974
|
0.75
|
|
33
|
A model for the pharmacist's involvement in high blood pressure control.
|
Fam Community Health
|
1981
|
0.75
|
|
34
|
Does antihypertensive therapy influence quality of life?
|
Clin Pharm
|
1989
|
0.75
|
|
35
|
Drug therapy assessments by pharmacists.
|
Am J Hosp Pharm
|
1980
|
0.75
|
|
36
|
Clinical pharmacy services for the hypercholesterolemic patient.
|
Am Pharm
|
1987
|
0.75
|
|
37
|
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
|
Pharmacoeconomics
|
1998
|
0.75
|
|
38
|
Patient behaviors that promote high blood pressure control.
|
Contemp Pharm Pract
|
1980
|
0.75
|
|
39
|
Editorial: the challenge of hypertension: turning professional inventory into action.
|
Am J Hosp Pharm
|
1975
|
0.75
|
|
40
|
Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidence.
|
J Womens Health Gend Based Med
|
1999
|
0.75
|
|
41
|
Effects of diltiazem hydrochloride on glucose tolerance in persons at risk for diabetes mellitus.
|
Clin Pharm
|
1988
|
0.75
|
|
42
|
Blood pressure screening in a community pharmacy.
|
J Am Pharm Assoc
|
1976
|
0.75
|
|
43
|
Helping the noncompliant, forgetful patient. A case history.
|
Home Healthc Nurse
|
1992
|
0.75
|
|
44
|
Introduction: missing the target with lipid-lowering therapy.
|
Am J Manag Care
|
2000
|
0.75
|
|
45
|
Effect of advanced pharmaceutical services on the incidence of adverse drug reactions.
|
Am J Hosp Pharm
|
1979
|
0.75
|
|
46
|
Return of the apothecary.
|
Arch Intern Med
|
1981
|
0.75
|
|
47
|
Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.
|
Am J Manag Care
|
2000
|
0.75
|
|
48
|
Alternative pharmacologic approaches to the initial management of hypertension.
|
Drug Intell Clin Pharm
|
1985
|
0.75
|
|
49
|
Improving cholesterol control in managed care populations.
|
Am J Manag Care
|
2000
|
0.75
|